Company Search:
Advanced Search
Sponsored Links
Pharmena SA Company Snapshot
Pharmena SA operates within the Toilet preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmena SA with three other cosmetics and toiletry producers in Europe: Albus a.d. Novi Sad of Serbia (2017 sales of 535.65 million Serbian Dinars [US$5.20 million] ), Miraculum SA (20.21 million Polish New Zlotys [US$5.41 million] ), and Bulgarska Rosa AD which is based in Bulgaria (6.62 million Bulgarian Lev [US$3.89 million] ).

Sales Analysis. During the year ended December of 2017, sales at Pharmena SA were 12.51 million Polish New Zlotys (US$3.35 million). This is a decrease of 21.4% versus 2016, when the company's sales were 15.91 million Polish New Zlotys. Contributing to the drop in overall sales was the 21.4% decline in Merchandise, from 15.91 million Polish New Zlotys to 12.51 million Polish New Zlotys. .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pharmena SA
  Stock Performance Chart for Pharmena SA
  Stock Data: Recent Stock Performance:
  Current Price (10/19/2018): 6.50
(Figures in Polish New Zlotys)
1 Week 0.0%   13 Weeks -10.3%  
4 Weeks -30.9%   52 Weeks -69.0%  
Pharmena SA Key Data:
  Ticker: PHR Country: Poland
  Exchanges: WAR Major Industry: Household & Personal Products
    Sub Industry: Toilet Preparations
  2017 Sales 12,511,000
(Year Ending Jan 2018).
Employees: 20
  Currency: Polish New Zlotys Market Cap: 57,167,838
  Fiscal Yr Ends: December Shares Outstanding: 8,795,052
  Share Type: Akcje Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.